JNCCN-360

Editors:

James L. Mohler, MD

Richard J. Lee, MD, PhD

Advertisement

Advertisement

Carmel Jo Pezaro, MB, ChB, on Prostate Cancer and PARP Inhibitors

Peter R. Carroll, MD, MPH, on Prostate Cancer: Risks of Early Detection

James L. Mohler, MD, on Prostate Cancer: Management Approaches

Recent

FDA Approves Enzalutamide for Castration-Resistant Prostate Cancer

Survey Shows Higher Suicide Rate in Patients With Urologic Cancers

SNMMI 2018: Effect of Targeted Radionuclide Therapy on Metastasis in Prostate Cancer

Prostate Cancer Xenograft Derived From Circulating Tumor Cells

Published

Medical Literature

Clinical Associations of Luminal and Basal Subtyping in Prostate Cancer

ASCO Clinical Practice Guidelines for Metastatic Noncastrate Prostate Cancer

Robot-Assisted Radical Prostatectomy for Locally Advanced Prostate Cancer

Dose-Escalated Radiation Therapy for Intermediate-Risk Prostate Cancer

Ongoing

New Directions in Nonmetastatic CRPC: Perspectives on the Latest Data (login required)

Cases From the Community: Clinical Investigators Provide Their Perspectives on the Use of Immune Checkpoint Inhibitors in the Management of Actual Patients With Genitourinary Cancers

Metastatic CRPC: Clinical Strategies (login required)

Prostate Cancer Patient Management Simulator

Available

Clinical Trials

Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance

Yale Cancer Center

Duke Cancer Institute

Moffitt Cancer Center

Sections

NCCN Resources

Copyright © 2018 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.